Renal Cancer - Results from #160

Phase II Trial of Intermittent Therapy in Patients with Metastatic Renal Cell Carcinoma Treated with Front-line Ipilimumab and Nivolumab. September 5, 2024

Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma. September 5, 2024

Renal cell carcinoma: entering the age of biomarkers. September 4, 2024

Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma. September 4, 2024

Pathological Response and Outcomes in Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Immunotherapy-Based Therapies and Undergoing Deferred Cytoreductive Nephrectomy (CN). September 3, 2024

Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan. September 3, 2024

Impact of DPP4 Inhibition on Survival in Patients With Metastatic Renal Cell Carcinoma and Type 2 Diabetes Mellitus. September 2, 2024

KIR2DL2/DL3+NKs and Helios+Tregs in peripheral blood predict nivolumab response in patients with metastatic renal cell cancer. September 2, 2024

On-clamp vs off-clamp robot-assisted partial nephrectomy for achieving modified trifecta: inverse probability of treatment weighting analysis from a high-volume tertiary robotic center. September 2, 2024

Salvage stereotactic ablative body radiotherapy after thermal ablation of primary kidney cancer. August 30, 2024

Contemporary Management of Renal Cell Carcinoma: A Review for General Practitioners in Oncology. August 30, 2024

Impact of Timing of Immunotherapy and Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Real-World Data on Survival Outcomes from the CKCis Database. August 29, 2024

Renal Cell Carcinoma A Review August 28, 2024

Effect of race/ethnicity on survival in surgically treated intermediate/high risk non-metastatic clear cell renal carcinoma. August 28, 2024

APOBEC3C-mediated NF-κB activation enhances clear cell renal cell carcinoma progression. August 28, 2024

The influence of sex hormones on renal cell carcinoma. August 26, 2024

Disulfidptosis-associated LncRNA signature predicts prognosis and immune response in kidney renal clear cell carcinoma. August 26, 2024

Exploring the Feasibility of GPT-4 as a Data Extraction Tool for Renal Surgery Operative Notes. August 26, 2024

Banana-shaped survival curves of metastatic renal cell carcinoma treated with first-line immune-combinations, not just a matter of "palateau". August 26, 2024

Validation of the Meet-URO score in metastatic clear cell renal cell carcinoma patients receiving second or third-line tyrosine kinase inhibitors-immune checkpoint inhibitors combination therapy. August 26, 2024

Page 9 of 456